ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch
By filer · By stock

$ALNY:NASDAQ · ALNYLAM PHARMACEUTICALS INC

Sector: health

Conviction from: NASDAQ

52-week range: 197.81495.55

Alnylam Pharmaceuticals develops and markets RNA interference (RNAi) therapeutics for rare genetic, cardiometabolic, and other diseases.

4 tracked filer(s) hold this · 0 opened, 0 added, 3 trimmed in 30-JUN-2026

Aggregate 13FScore 59 — mean of 4 scored holder(s). Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Ancora40Holds (flat)11$3,3110.0%
Bridgewater56Trimmed -7%99,584$29,977,7720.1%
Paul Tudor Jones / Tudor63Trimmed -56%1,200$361,2360.0%
Steve Cohen / Point7276Trimmed -65%2,200$662,2660.0%

Beyond 13F — activists, insiders, politicians & research

Trump & executive branch trades all Trump/exec trades →

8 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-09-22Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-08-22Trump, Donald J PresidentSELL$15,001 - $50,000PTR
2026-07-01Trump, Donald J PresidentSELL$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-05-14Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-05-14Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-05-14Trump, Donald J PresidentSELL$1,001 -$15,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.